Cytiva VIA Thaw™ L1000 Dry-Heat Automated Cell Thawing System
| Brand | Cytiva |
|---|---|
| Origin | Switzerland |
| Model | VIA Thaw™ L1000 |
| Type | Fully Automated |
| Regulatory Classification | Import (CE-marked for IVD/medical device use in EU |
| Compliance | Designed to support GMP-compliant cell therapy manufacturing per ISO 13485, ASTM F3276-21 (Standard Guide for Cryopreserved Cellular Product Thawing), and 21 CFR Part 11–ready when used with Chronicle™ software |
Overview
The Cytiva VIA Thaw™ L1000 is a fully automated, dry-heat cell thawing system engineered for reproducible, controlled, and audit-ready recovery of cryopreserved cellular therapeutics—from clinical-grade CAR-T and TCR-T products to mesenchymal stromal cells (MSCs) and hematopoietic stem cells (HSCs). Unlike water-bath or ambient-air thawing methods, the VIA Thaw™ L1000 employs precisely regulated conductive heating via temperature-controlled aluminum plates, eliminating direct contact with liquids and mitigating contamination risk. Its closed-system architecture interfaces exclusively with standard cryobags (e.g., CryoBag®, BioLife, MacoPharma, Sartorius), ensuring consistent thermal transfer across variable bag geometries and fill volumes (10–275 mL). The system determines thaw endpoint dynamically using real-time, multi-point thermal sensing—monitoring both bag surface temperature and internal thermal gradient—to halt heating at the optimal moment: immediately after complete ice phase transition, prior to sustained hyperthermic exposure. This physics-based endpoint detection supports high post-thaw viability (>90% typical for validated protocols) and minimizes thermal stress-induced apoptosis.
Key Features
- Fully automated dry-heat thawing with no water bath, steam, or open-air exposure—reducing bioburden risk and enabling Class A/B cleanroom integration
- Multi-sensor thermal monitoring (surface + predictive core-equivalent temperature modeling) for precise, non-invasive endpoint determination
- Pre-validated, user-configurable thaw profiles—adjustable ramp rates (0.1–5°C/min), hold durations, and endpoint thresholds (±0.2°C accuracy)
- Integrated barcode reader for lot-level traceability of cryobags, operators, and thaw protocols
- Modular hardware design compliant with ISO 14644-1 Class 5 airflow requirements when installed with appropriate enclosures
- Self-diagnostics and automated calibration verification logs generated before each run
Sample Compatibility & Compliance
The VIA Thaw™ L1000 accommodates single-use cryopreservation bags conforming to ISO 15797 and ASTM F2873 standards, including flat-panel and U-bottom configurations. It supports volume ranges from 10 mL (pediatric doses) to 275 mL (large-scale allogeneic batches), maintaining thermal uniformity across all formats without mechanical repositioning. All thaw cycles are executed under documented conditions aligned with ICH Q5D (Quality of Biotechnological Products: Derivation and Characterization of Cell Substrates), USP (Assessment of Cell-Based Therapies), and EMA’s Guideline on Human Cell-Based Medicinal Products. When operated with Chronicle™ software, the system generates 21 CFR Part 11–compliant electronic batch records—including full audit trails, electronic signatures, and immutable timestamped event logs—meeting GMP requirements for ATMP (Advanced Therapy Medicinal Product) manufacturing environments.
Software & Data Management
Chronicle™ automation software serves as the centralized control and documentation layer for the VIA Thaw™ L1000. It enables cross-site profile synchronization, version-controlled protocol libraries, and role-based access control (RBAC) for operators, supervisors, and QA reviewers. Each thaw cycle exports structured data (CSV/JSON) containing time-stamped temperature curves, sensor diagnostics, operator inputs, and deviation flags. Chronicle™ supports integration with LIMS (e.g., LabVantage, STARLIMS) and MES platforms via RESTful API. Electronic Standard Operating Procedure (eSOP) overlays can be embedded directly into run interfaces, with mandatory acknowledgment steps for critical actions (e.g., “Confirm bag orientation” or “Verify pre-thaw QC release”). All data—including annotations, alarm history, and maintenance logs—is retained for ≥25 years per ALCOA+ principles (Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, Available).
Applications
- Release testing and clinical administration of autologous and allogeneic cell therapies
- GMP-compliant manufacturing scale-up in centralized cell processing facilities
- Process validation studies requiring statistical demonstration of thaw consistency (e.g., Ppk ≥1.33 across ≥30 consecutive runs)
- Comparative thaw optimization for novel cryoprotectants or freezing media formulations
- Regulatory submission support—including analytical method validation packages and process characterization reports
FAQ
Does the VIA Thaw™ L1000 require external water or gas supplies?
No. It operates solely on electrical power (230 V AC, 50/60 Hz) and requires no plumbing, compressed air, or cooling water connections.
Can thaw profiles be qualified per USP or ASTM F3276?
Yes. Cytiva provides qualification templates (IQ/OQ/PQ) and supports protocol-specific validation services through its Global Validation Services team.
Is the system compatible with single-use bioreactor or fill-finish workflows?
It integrates natively with common aseptic transfer platforms (e.g., Corning Ascent™, Sartorius Ambr®) via digital handshake protocols and can trigger downstream equipment start commands upon thaw completion.
What cybersecurity standards does Chronicle™ meet?
Chronicle™ complies with IEC 62443-3-3 SL2 for industrial automation systems and includes TLS 1.2+ encryption, secure boot, and regular third-party penetration testing reports.
How is firmware updated, and is downtime required?
Firmware updates are delivered over secure HTTPS and applied during scheduled maintenance windows; no runtime interruption is needed—thaw cycles continue uninterrupted during background update staging.
